- Home
- AVAV vs EXEL Comparison
AVAV vs EXEL Comparison
Compare AVAV & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAV
- EXEL
- Stock Information
- Founded
- AVAV 1971
- EXEL 1994
- Country
- AVAV United States
- EXEL United States
- Employees
- AVAV N/A
- EXEL N/A
- Industry
- AVAV Aerospace
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVAV Industrials
- EXEL Health Care
- Exchange
- AVAV Nasdaq
- EXEL Nasdaq
- Market Cap
- AVAV 12.1B
- EXEL 10.4B
- IPO Year
- AVAV 2007
- EXEL 2000
- Fundamental
- Price
- AVAV $265.87
- EXEL $39.14
- Analyst Decision
- AVAV Strong Buy
- EXEL Buy
- Analyst Count
- AVAV 12
- EXEL 21
- Target Price
- AVAV $288.17
- EXEL $43.65
- AVG Volume (30 Days)
- AVAV 982.9K
- EXEL 2.2M
- Earning Date
- AVAV 09-09-2025
- EXEL 10-28-2025
- Dividend Yield
- AVAV N/A
- EXEL N/A
- EPS Growth
- AVAV N/A
- EXEL 81.76
- EPS
- AVAV N/A
- EXEL 2.08
- Revenue
- AVAV $1,085,820,000.00
- EXEL $2,230,005,000.00
- Revenue This Year
- AVAV $149.08
- EXEL $9.24
- Revenue Next Year
- AVAV $15.36
- EXEL $13.04
- P/E Ratio
- AVAV N/A
- EXEL $18.75
- Revenue Growth
- AVAV 44.03
- EXEL 10.73
- 52 Week Low
- AVAV $102.25
- EXEL $25.17
- 52 Week High
- AVAV $295.90
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- AVAV 63.10
- EXEL 54.38
- Support Level
- AVAV $225.75
- EXEL $38.37
- Resistance Level
- AVAV $257.07
- EXEL $39.27
- Average True Range (ATR)
- AVAV 11.14
- EXEL 0.98
- MACD
- AVAV 2.85
- EXEL 0.31
- Stochastic Oscillator
- AVAV 98.79
- EXEL 87.13
About AVAV AeroVironment Inc.
AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.